Clinical Experience with the SeriScaffold® Device, a Silk-Derived Bioresorbable Scaffold, in Two-Stage Implant-Based Breast Reconstruction

2012 ◽  
Vol 130 ◽  
pp. 34-35
Author(s):  
Mark Jewell ◽  
Neil A. Fine ◽  
Max R. Lehfeldt ◽  
Susan E. Downey ◽  
Gabriel M. Kind ◽  
...  
2014 ◽  
Vol 40 (5) ◽  
pp. 621 ◽  
Author(s):  
Nolan Karp ◽  
Mihye Choi ◽  
Jeff Ippolito ◽  
Max Lehfeldt ◽  
Mark Jewell ◽  
...  

BMJ Open ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. e044219
Author(s):  
J X Harmeling ◽  
Kevin Peter Cinca ◽  
Eleni-Rosalina Andrinopoulou ◽  
Eveline M L Corten ◽  
M A Mureau

IntroductionTwo-stage implant-based breast reconstruction is the most commonly performed postmastectomy reconstructive technique. During the first stage, a tissue expander creates a sufficiently large pocket for the definite breast implant placed in the second stage. Capsular contracture is a common long-term complication associated with implant-based breast reconstruction, causing functional complaints and often requiring reoperation. The exact aetiology is still unknown, but a relationship between the outer surface of the implant and the probability of developing capsular contracture has been suggested. The purpose of this study is to determine whether polyurethane-covered implants result in a different capsular contracture rate than textured implants.Methods and analysisThe Textured Implants versus Polyurethane-covered Implants (TIPI) trial is a multicentre randomised controlled trial with a 1:1 allocation rate and a follow-up of 10 years. A total of 321 breasts of female adults undergoing a two-stage breast reconstruction will be enrolled. The primary outcome is capsular contracture at 10-year follow-up which is graded with the modified Baker classification. It is analysed with survival analysis using a frailty model for clustered interval-censored data, with both an intention-to-treat and per-protocol approach. Secondary outcomes are other complication rates, surgical revision rate, patient satisfaction and quality of life and user-friendliness. Outcomes are measured 2 weeks, 6 months, 1, 2, 3, 5 and 10 years postoperatively. Interim analysis is performed when 1-year, 3-year and 5-year follow-up is completed.Ethics and disseminationThe trial has been reviewed and approved by the Medical Research Ethics Committee of the Erasmus MC, University Medical Centre Rotterdam (MEC-2018-126) and locally by each participating centre. Written informed consent will be obtained from each study participant. The results will be disseminated by publication in peer-reviewed journals.Trial registrationNTR7265.


2016 ◽  
Vol 43 (2) ◽  
pp. 197-203 ◽  
Author(s):  
Jiajun Feng ◽  
Cleone I Pardoe ◽  
Ashley Manuel Mota ◽  
Christopher Hoe Kong Chui ◽  
Bien-Keem Tan

2019 ◽  
Vol 33 (04) ◽  
pp. 264-269 ◽  
Author(s):  
Aurelia Trisliana Perdanasari ◽  
Amjed Abu-Ghname ◽  
Sarth Raj ◽  
Sebastian J. Winocour ◽  
Rene D. Largo

AbstractImplant-based reconstruction (IBR) remains the most commonly utilized breast reconstruction option for post-mastectomy patients. IBR can be approached as either a one-stage reconstruction or a two-stage reconstruction. Facilitated by improvements in surgical technology and advanced techniques, one-stage reconstruction, also known as direct-to-implant (DTI) reconstruction, involves the insertion of an implant at the time of mastectomy. The decision to pursue either a DTI or a two-stage reconstruction is based on several factors, including the patient's overall health, expected risk of postoperative complications, and associated costs to both the patient and hospital.


2012 ◽  
Vol 130 (1) ◽  
pp. 1-9 ◽  
Author(s):  
Scott L. Spear ◽  
Mitchel Seruya ◽  
Samir S. Rao ◽  
Steven Rottman ◽  
Ellen Stolle ◽  
...  

2019 ◽  
Vol 72 (11) ◽  
pp. 1763-1768 ◽  
Author(s):  
Jens H. Hoejvig ◽  
Nicolas J. Pedersen ◽  
Christina S. Gramkow ◽  
Rikke Bredgaard ◽  
Niels Kroman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document